Carrie Hurwitz Williams has been promoted from principal while Jennifer Carter will add the role to her vice-president of portfolio development, marketing and venture operations position.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University hospital Charité’s sinus surgery spinout Fiagon Medical has been acquired for more than $70m, with Cascara Ventures and Donghai Securities also scoring exits.

Graphite Bio's first drug program will target sickle cell anaemia based on innovations in DNA editing from Stanford University.

Lilly Asia Ventures achieved an exit as the gastrointestinal and liver disease drug developer priced its initial public offering in the middle of its range.

Tencent Trusted Doctors has partnered China Resources' CR Capital fund to establish a healthcare industry fund focusing on the city of Chengdu.

The autoreactive and neuro-inflammatory disease therapy developer closed a $77.5m round co-led by Sanofi Ventures that took its total funding to more than $117m.

The precision medicine developer attracted returning investors Novo, Novartis Venture Fund and Johnson & Johnson Innovation – JJDC for a crossover financing round.

Escape Bio, a spinout of Gladstone Institutes, has secured the return of Osage University Partners, Novartis, Novo and Johnson & Johnson.

The investment firm supplied $50m for telehealth platform developer MDLive, which already counts Sentara, Cigna, Sutter Health, Novo and HCSC as investors.